Finance

Beta
Lists
ALT:NASDAQ
Altimmune Inc
$2.71
-7.19%
(-0.21) 1D
$2.70
-0.23% (-0.0061)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALT...
Open
$2.92
High
$2.92
Low
$2.68
Mkt. cap
527.02M
Avg. vol.
4.68M
Volume
3.13M
52-wk high
$7.73
52-wk low
$2.56
EPS
-$0.92
Beta
0.22
Shares outstanding
194.47M
No. of employees
57
Open
$2.92
High
$2.92
Low
$2.68
Mkt. cap
527.02M
Avg. vol.
4.68M
Volume
3.13M
52-wk high
$7.73
52-wk low
$2.56
EPS
-$0.92
Beta
0.22
Shares outstanding
194.47M
No. of employees
57
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to ALT in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ALT in the last 3 months.
Highest
Current $2.71
$20.00 (+638.01%)
Average
$13.38 (+393.73%)
Lowest
$2.50 (-7.75%)
News stories
From sources across the web
About Altimmune Inc
CEOJerry Durso
Employees57
Founded1997
HeadquartersGaithersburg, Maryland, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.00K
5.00K
26.00K
-
Cost of goods sold
17.24M
14.96M
18.41M
15.48M
Cost of revenue
17.24M
14.96M
18.41M
15.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.69M
5.90M
10.51M
8.05M
Operating expense
5.69M
5.90M
10.51M
8.05M
Total operating expenses
22.93M
20.86M
28.92M
23.54M
Operating income
-22.92M
-20.86M
-28.89M
-23.54M
Other non operating income
-92.00K
-86.00K
-27.00K
-152.00K
EBT including unusual items
-22.15M
-19.01M
-27.36M
-22.56M
EBT excluding unusual items
-22.15M
-19.01M
-27.36M
-21.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22.15M
-19.01M
-27.36M
-22.56M
Net profit margin
-442,920.00%
-380,280.00%
-105,223.08%
-
Earnings per share
-0.27
-0.21
-0.27
-0.18
Interest and investment income
1.13M
2.43M
2.44M
2.90M
Interest expense
-264.00K
-495.00K
-876.00K
-1.07M
Net interest expenses
868.00K
1.93M
1.56M
1.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.89M
-20.83M
-28.87M
-23.51M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more